Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd > Speaking out loudly

<< Previous

Bullboard Posts

Next >>

Comment by GoldenArmon Jul 25, 2022 1:48pm

204 Views

Post# 34848752

RE:Speaking out loudly

Despite the virus, the tech is brilliant. They could be the first biotech company to actually create a vaccine that protects against respiratory virus. We know mRNA doesn't work and is more of a therapuetic than a vaccine.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season